Arthritis Research UK is the resource for anyone looking for the latest news in the fight against arthritis. We’re providing answers today and tomorrow toward a future free from arthritis.
A maximum of 200 results have been returned
New one-year clinical trial results have demonstrated the sustained efficacy the drug secukinumab can provide in the treatment of ankylosing spondylitis patients.
Find out more
A new study has shown that subcutaneous tocilizumab can offer similar efficacy to the intravenous formulation in the treatment of rheumatoid arthritis.
A study has identified risk factors for serious infections in patients with rheumatoid arthritis treated with abatacept, including old age and a past history of infections.
NICE has published final guidance recommending ustekinumab, also known as Stelara, for the treatment of psoriatic arthritis within the NHS.
People with knee osteoarthritis experience pain more intensely when it is accompanied by poor sleep and negative attitudes, according to research.
A world-first vaccine-style therapeutic approach to treat rheumatoid arthritis has been developed by Australian researchers.
A new US population-based study has indicated that cardiovascular disease risk is higher in ankylosing spondylitis patients than is currently assumed.
A new study has indicated that dosage tapering is potentially suitable for some, though not all, ankylosing spondylitis patients being treated with etanercept.
As many as six million Britons may be living with undiagnosed back pain, due to a lack of access to treatment, poor advice and sedentary lifestyles.
The number of over-50s at high risk of osteoporotic fracture worldwide is set to double by 2040, according to new UK research.